Kevin Kemp

2.7k total citations
70 papers, 2.1k citations indexed

About

Kevin Kemp is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kevin Kemp has authored 70 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 20 papers in Genetics and 17 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kevin Kemp's work include Mesenchymal stem cell research (19 papers), Neurogenesis and neuroplasticity mechanisms (13 papers) and Genetic Neurodegenerative Diseases (9 papers). Kevin Kemp is often cited by papers focused on Mesenchymal stem cell research (19 papers), Neurogenesis and neuroplasticity mechanisms (13 papers) and Genetic Neurodegenerative Diseases (9 papers). Kevin Kemp collaborates with scholars based in United Kingdom, United States and Denmark. Kevin Kemp's co-authors include Alastair Wilkins, Neil Scolding, Kelly Hares, Elizabeth Mallam, Claire M Rice, Mark Ginty, Elizabeth Gray, Jill Hows, Craig Donaldson and Juliana Redondo and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Kevin Kemp

68 papers receiving 2.0k citations

Peers

Kevin Kemp

GENET

CMN

PFM

Fernando Carceller Spain

Yongchao Ma China

Elisabet Lindqvist Sweden

Xuelian He China

Suh Young Jeong United States

Astrid Jeibmann Germany

Naoya Yamamoto Japan

Pablo Martı́n-Vasallo Spain

Ou Jin China

Fernando Carceller Spain

Kevin Kemp

917 ×1.1

364 ×0.5

GENET

516 ×1.4

CMN

209 ×0.7

175 ×0.7

PFM

Citations per year, relative to Kevin Kemp Kevin Kemp (= 1×) peers Fernando Carceller

Countries citing papers authored by Kevin Kemp

Since Specialization

Citations

This map shows the geographic impact of Kevin Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Kemp more than expected).

Fields of papers citing papers by Kevin Kemp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Kemp. The network helps show where Kevin Kemp may publish in the future.

Co-authorship network of co-authors of Kevin Kemp

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Kemp. A scholar is included among the top collaborators of Kevin Kemp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Kemp. Kevin Kemp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kemp, Kevin, Kelly Hares, Juliana Redondo, et al.. (2022). An open-label pilot study of recombinant granulocyte-colony stimulating factor in Friedreich’s ataxia. Nature Communications. 13(1). 4655–4655. 2 indexed citations

Hares, Kelly, Kevin Kemp, Samantha Loveless, et al.. (2021). KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis. Journal of Neurology. 268(6). 2175–2184. 7 indexed citations

Haynes, Harry R., Kelly Hares, Juliana Redondo, et al.. (2018). Evaluation of the quality of RNA extracted from archival FFPE glioblastoma and epilepsy surgical samples for gene expression assays. Journal of Clinical Pathology. 71(8). 695–701. 13 indexed citations

Kemp, Kevin, et al.. (2018). Aberrant cerebellar Purkinje cell function repaired in vivo by fusion with infiltrating bone marrow-derived cells. Acta Neuropathologica. 135(6). 907–921. 15 indexed citations

Redondo, Juliana, Kevin Kemp, Mark Ginty, et al.. (2017). Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis. Cytotherapy. 20(1). 21–28. 29 indexed citations

Kemp, Kevin, Juliana Redondo, Kelly Hares, et al.. (2016). Oxidative injury in multiple sclerosis cerebellar grey matter. Brain Research. 1642. 452–460. 22 indexed citations

Kemp, Kevin, Alastair Wilkins, & Neil Scolding. (2014). Cell fusion in the brain: two cells forward, one cell back. Acta Neuropathologica. 128(5). 629–638. 28 indexed citations

Gray, Elizabeth, Kevin Kemp, Kelly Hares, et al.. (2014). Increased microglial catalase activity in multiple sclerosis grey matter. Brain Research. 1559. 55–64. 21 indexed citations

Kemp, Kevin, et al.. (2013). The Platform Protein Is Essential for Type IV Pilus Biogenesis. Journal of Biological Chemistry. 288(14). 9721–9728. 84 indexed citations

10.

Kemp, Kevin, et al.. (2012). Human Mesenchymal Stem Cells Increase Anti-oxidant Defences in Cells Derived from Patients with Friedreich’s Ataxia. The Cerebellum. 11(4). 861–871. 22 indexed citations

11.

Gray, Elizabeth, Mark Ginty, Kevin Kemp, Neil Scolding, & Alastair Wilkins. (2012). The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function. Journal of Neuroinflammation. 9(1). 63–63. 79 indexed citations

12.

Nightingale, Helen, Kevin Kemp, Elizabeth Gray, et al.. (2011). Changes in Expression of the Antioxidant Enzyme SOD3 Occur Upon Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells In Vitro. Stem Cells and Development. 21(11). 2026–2035. 31 indexed citations

13.

Gray, Elizabeth, Mark Ginty, Kevin Kemp, Neil Scolding, & Alastair Wilkins. (2011). Peroxisome proliferator-activated receptor-α agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function. European Journal of Neuroscience. 33(8). 1421–1432. 31 indexed citations

14.

Kemp, Kevin, Elizabeth Gray, Elizabeth Mallam, Neil Scolding, & Alastair Wilkins. (2010). Inflammatory Cytokine Induced Regulation of Superoxide Dismutase 3 Expression by Human Mesenchymal Stem Cells. Stem Cell Reviews and Reports. 6(4). 548–559. 62 indexed citations

15.

Kemp, Kevin, Sarah Wexler, Christine Cox, et al.. (2010). Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy. Annals of Hematology. 89(7). 701–713. 48 indexed citations

16.

Kemp, Kevin, David J. Gordon, David C. Wraith, et al.. (2010). Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells. Neuropathology and Applied Neurobiology. 37(2). 166–178. 60 indexed citations

17.

Kemp, Kevin, Kelly Hares, Elizabeth Mallam, et al.. (2009). Mesenchymal stem cell‐secreted superoxide dismutase promotes cerebellar neuronal survival. Journal of Neurochemistry. 114(6). 1569–1580. 98 indexed citations

18.

Wilkins, Alastair, Kevin Kemp, Mark Ginty, et al.. (2009). Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Research. 3(1). 63–70. 225 indexed citations

19.

Kemp, Kevin & Stefan Wurm. (2006). EUV lithography. Comptes Rendus Physique. 7(8). 875–886. 49 indexed citations

20.

Larsen, E.H., Asger B. Hansen, L. Kristensen, et al.. (1992). ICP-MS, INAA and PIXE analysis of airborne dust samples. 10(1). 43–54. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact